Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-12 Purchase |
2024-09-16 4:56 pm |
Chromocell Therapeutics Corp | CHRO | Malamut Richard Director |
10,400 | $0.9447 | $9,825 | 91,565 (Indirect) |
View |
| 2024-09-12 Purchase |
2024-09-16 4:55 pm |
Chromocell Therapeutics Corp | CHRO | Francis Knuettel II CEO, Pres., CFO, Treas & Secty |
5,200 | $0.97 | $5,044 | 547,710 (Indirect) |
View |
| 2024-09-10 Purchase |
2024-09-12 5:35 pm |
Chromocell Therapeutics Corp | CHRO | Francis Knuettel II CEO, Pres., CFO, Treas & Secty |
12,000 | $0.91292 | $10,955 | 542,510 (Indirect) |
View |
| 2024-02-21 Purchase(A) |
2024-03-12 4:05 pm |
Chromocell Therapeutics Corp | CHRO | Friedberg Ezra M Director |
16,667 | $6 | $100,002 | 545,721 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-02 Option Award |
2025-07-23 9:17 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Plesha Scott M. CEO and President |
338,678 | $0 | 338,678 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-21 8:26 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Rangarao Sai Chief Commercial Officer |
123,518 | $0 | 123,518 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-07 9:47 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Baxter Richard B Director |
77,338 | $0 | 77,338 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-07 9:46 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Greenleaf Peter Director |
103,118 | $0 | 103,118 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-07 9:45 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Pauls Matthew Director |
103,118 | $0 | 103,118 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-07 9:44 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II CFO, Treas & Secty |
135,472 | $0 | 178,546 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-07 9:43 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director |
77,338 | $0 | 95,199 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-07 9:42 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director |
77,338 | $0 | 86,242 (Direct) |
View |
| 2025-07-02 Option Award |
2025-07-07 9:41 pm |
2026-07-02 2035-07-02 |
Pelthos Therapeutics Inc. | PTHS | Malamut Richard Director |
77,338 | $0 | 86,242 (Direct) |
View |
| 2025-07-01 Conversion |
2025-07-03 9:05 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director |
40,000 | $10 | 174,573 (Indirect) |
View |
| 2025-07-01 Conversion |
2025-07-03 9:05 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Friedberg Ezra M Director |
80,000 | $0 | 174,573 (Indirect) |
View |
| 2025-07-01 Conversion |
2025-07-03 9:04 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II Chief Financial Officer |
10,000 | $10 | 32,816 (Indirect) |
View |
| 2025-07-01 Other |
2025-07-03 9:04 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II Chief Financial Officer |
10,000 | $0 | 32,816 (Indirect) |
View |
| 2025-07-01 Conversion |
2025-07-03 9:04 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Francis Knuettel II Chief Financial Officer |
10,000 | $0 | 32,816 (Indirect) |
View |
| 2025-07-01 Conversion |
2025-07-03 9:02 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director 10% Owner |
1,500,000 | $10 | 4,633,785 (Indirect) |
View |
| 2025-07-01 Other |
2025-07-03 9:02 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director 10% Owner |
31,279 | $0 | 4,633,785 (Indirect) |
View |
| 2025-07-01 Conversion |
2025-07-03 9:02 pm |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director 10% Owner |
15,000 | $0 | 4,633,785 (Indirect) |
View |
| 2025-07-01 Conversion |
2025-07-03 09:33 am |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | LIGAND PHARMACEUTICALS INC 10% Owner |
1,500,000 | $10 | 1,537,279 (Direct) |
View |
| 2025-07-01 Other |
2025-07-03 09:33 am |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | LIGAND PHARMACEUTICALS INC 10% Owner |
31,279 | $0 | 1,537,279 (Direct) |
View |
| 2025-07-01 Conversion |
2025-07-03 09:33 am |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | LIGAND PHARMACEUTICALS INC 10% Owner |
15,000 | $0 | 1,537,279 (Direct) |
View |
Ownership |
2025-07-03 09:28 am |
N/A N/A |
Pelthos Therapeutics Inc. | PTHS | LIGAND PHARMACEUTICALS INC 10% Owner |
0 | $0 | 1,800,000 (Direct) |
View |
| 2025-04-11 Option Award |
2025-04-15 9:31 pm |
N/A 2035-04-11 |
Channel Therapeutics Corp | CHRO | Simmons Chia-Lin Director |
25,000 | $0 | 130,000 (Direct) |
View |
| 2025-04-11 Option Award |
2025-04-15 9:30 pm |
N/A 2035-04-11 |
Channel Therapeutics Corp | CHRO | Francis Knuettel II CEO, Pres., CFO, Treas & Secty |
53,988 | $0 | 430,736 (Direct) |
View |
| 2024-11-13 Option Award |
2024-11-15 4:22 pm |
N/A 2024-11-13 |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
49,605 | $0 | 263,306 (Direct) |
View |
| 2024-11-13 Option Award |
2024-11-15 4:20 pm |
N/A 2024-11-13 |
Chromocell Therapeutics Corp | CHRO | Malamut Richard Director |
24,533 | $0 | 116,098 (Direct) |
View |
| 2024-11-13 Option Award |
2024-11-15 4:19 pm |
N/A 2024-11-13 |
Chromocell Therapeutics Corp | CHRO | Friedberg Ezra M Director |
24,533 | $0 | 634,752 (Direct) |
View |
| 2024-06-28 Gift |
2024-07-02 5:17 pm |
N/A N/A |
Chromocell Therapeutics Corp | CHRO | Francis Knuettel II CEO, Pres., CFO Treas & Secty |
20,000 | $0 | 515,510 (Direct) |
View |
Ownership(A) |
2024-07-02 5:15 pm |
N/A N/A |
Chromocell Therapeutics Corp | CHRO | Francis Knuettel II CEO, Pres., CFO, Treas & Secty |
0 | $0 | 130,953 (Direct) |
View |
| 2024-02-21 Option Award(A) |
2024-06-18 8:07 pm |
2024-02-21 2033-01-10 |
Chromocell Therapeutics Corp | CHRO | Francis Knuettel II CEO, Pres., CFO Treas & Secty |
2,778 | $0 | 25,001 (Indirect) |
View |
| 2024-06-14 Option Award |
2024-06-18 8:06 pm |
N/A 2034-06-14 |
Chromocell Therapeutics Corp | CHRO | Simmons Chia-Lin Director |
90,000 | $0 | 105,000 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 8:05 pm |
N/A 2034-06-14 |
Chromocell Therapeutics Corp | CHRO | Lang Eric Chief Medical Officer |
130,000 | $0 | 154,223 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 8:03 pm |
N/A 2034-06-14 |
Chromocell Therapeutics Corp | CHRO | Friedberg Ezra M Director |
64,498 | $0 | 610,219 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 8:02 pm |
N/A 2034-06-14 |
Chromocell Therapeutics Corp | CHRO | Malamut Richard Director |
64,498 | $0 | 81,165 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 8:01 pm |
2024-06-14 2034-06-14 |
Chromocell Therapeutics Corp | CHRO | Francis Knuettel II CEO, Pres., CFO Treas & Secty |
351,778 | $0 | 429,556 (Indirect) |
View |
| 2024-06-14 Option Award |
2024-06-18 8:00 pm |
N/A 2034-06-14 |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
128,977 | $0 | 213,701 (Direct) |
View |
| 2024-02-21 Option Award |
2024-02-23 5:17 pm |
2024-02-21 2033-01-10 |
Chromocell Therapeutics Corp | CHRO | Francis Knuettel II Interim CEO, CFO Treas & Secty |
2,778 | $0 | 25,001 (Indirect) |
View |
| 2024-02-21 Conversion |
2024-02-23 5:15 pm |
2024-02-21 2024-02-29 |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
175,000 | $0 | 29,167 (Direct) |
View |
| 2024-02-21 Exercise |
2024-02-23 5:15 pm |
N/A N/A |
Chromocell Therapeutics Corp | CHRO | Davis Todd C Director |
29,167 | $4.8 | 29,167 (Direct) |
View |
| 2024-02-21 Conversion |
2024-02-23 5:12 pm |
2024-02-21 2024-02-29 |
Chromocell Therapeutics Corp | CHRO | Friedberg Ezra M Director |
98,650 | $0 | 520,719 (Indirect) |
View |
| 2024-02-21 Exercise |
2024-02-23 5:12 pm |
N/A N/A |
Chromocell Therapeutics Corp | CHRO | Friedberg Ezra M Director |
20,641 | $4.8 | 520,719 (Indirect) |
View |